Stryker Debt to Equity Ratio 2010-2025 | SYK

Current and historical debt to equity ratio values for Stryker (SYK) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Stryker debt/equity for the three months ending March 31, 2025 was 0.69.
Stryker Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2025-03-31 $25.08B $20.93B 1.20
2024-12-31 $22.34B $20.63B 1.08
2024-09-30 $23.68B $20.15B 1.18
2024-06-30 $19.37B $19.76B 0.98
2024-03-31 $20.23B $19.17B 1.06
2023-12-31 $21.32B $18.59B 1.15
2023-09-30 $20.14B $17.91B 1.13
2023-06-30 $20.05B $17.36B 1.16
2023-03-31 $19.94B $16.90B 1.18
2022-12-31 $20.27B $16.62B 1.22
2022-09-30 $19.52B $16.46B 1.19
2022-06-30 $20.36B $15.67B 1.30
2022-03-31 $21.09B $15.05B 1.40
2021-12-31 $19.75B $14.88B 1.33
2021-09-30 $19.97B $14.18B 1.41
2021-06-30 $19.88B $13.82B 1.44
2021-03-31 $19.95B $13.50B 1.48
2020-12-31 $21.25B $13.08B 1.62
2020-09-30 $19.30B $12.99B 1.49
2020-06-30 $18.73B $12.75B 1.47
2020-03-31 $16.33B $13.12B 1.25
2019-12-31 $17.36B $12.81B 1.36
2019-09-30 $14.34B $12.32B 1.17
2019-06-30 $14.41B $11.94B 1.21
2019-03-31 $14.24B $11.69B 1.22
2018-12-31 $15.50B $11.73B 1.32
2018-09-30 $12.22B $9.86B 1.24
2018-06-30 $12.11B $9.46B 1.28
2018-03-31 $12.91B $9.22B 1.40
2017-12-31 $12.22B $9.98B 1.22
2017-09-30 $11.06B $10.43B 1.06
2017-06-30 $11.26B $10.04B 1.12
2017-03-31 $10.81B $9.70B 1.11
2016-12-31 $10.89B $9.55B 1.14
2016-09-30 $10.86B $9.33B 1.16
2016-06-30 $11.42B $9.10B 1.26
2016-03-31 $10.86B $8.81B 1.23
2015-12-31 $7.71B $8.51B 0.91
2015-09-30 $7.43B $8.48B 0.88
2015-06-30 $8.31B $8.51B 0.98
2015-03-31 $8.26B $8.32B 0.99
2014-12-31 $8.68B $8.60B 1.01
2014-09-30 $8.89B $8.62B 1.03
2014-06-30 $8.23B $9.00B 0.91
2014-03-31 $7.10B $9.06B 0.78
2013-12-31 $6.70B $9.05B 0.74
2013-09-30 $6.15B $8.74B 0.70
2013-06-30 $5.78B $8.60B 0.67
2013-03-31 $5.63B $8.46B 0.67
2012-12-31 $4.61B $8.60B 0.54
2012-09-30 $4.42B $8.36B 0.53
2012-06-30 $4.31B $7.95B 0.54
2012-03-31 $4.44B $8.02B 0.55
2011-12-31 $4.46B $7.68B 0.58
2011-09-30 $4.53B $7.56B 0.60
2011-06-30 $3.82B $7.78B 0.49
2011-03-31 $3.78B $7.45B 0.51
2010-12-31 $3.72B $7.17B 0.52
2010-09-30 $3.47B $7.31B 0.47
2010-06-30 $3.32B $6.75B 0.49
2010-03-31 $3.43B $6.67B 0.51
2009-12-31 $2.48B $6.60B 0.38
2009-09-30 $2.02B $6.44B 0.31
2009-06-30 $1.87B $6.06B 0.31
2009-03-31 $1.96B $5.63B 0.35
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $148.668B $22.595B
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $232.025B 27.90
Boston Scientific (BSX) United States $151.510B 37.93
EssilorLuxottica (ESLOY) France $135.285B 0.00
Medtronic (MDT) Ireland $113.608B 16.10
Lonza Group Ag (LZAGY) Switzerland $50.270B 0.00
Haleon (HLN) United Kingdom $45.147B 25.77
ResMed (RMD) United States $37.623B 28.26
GE HealthCare Technologies (GEHC) United States $34.433B 16.35
Agilent Technologies (A) United States $34.375B 22.41
Terumo (TRUMY) Japan $24.785B 32.19
Koninklijke Philips (PHG) Netherlands $23.187B 16.27
Insulet (PODD) United States $20.867B 81.91
Zimmer Biomet Holdings (ZBH) United States $18.493B 11.88
Baxter (BAX) United States $15.734B 11.75
Smith & Nephew SNATS (SNN) United Kingdom $13.038B 0.00
Demant (WILYY) Denmark $8.971B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.823B 23.74
Lantheus Holdings (LNTH) United States $5.702B 14.38
Prestige Consumer Healthcare (PBH) United States $3.885B 17.35
Perrigo (PRGO) Ireland $3.731B 9.46
Haemonetics (HAE) United States $3.650B 16.62
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.415B 28.38
ICU Medical (ICUI) United States $3.262B 24.05
QuidelOrtho (QDEL) United States $2.084B 14.34
LeMaitre Vascular (LMAT) United States $1.896B 42.38
AtriCure (ATRC) United States $1.566B 0.00
Acuren (TIC) United States $1.379B 0.00
AdaptHealth (AHCO) United States $1.286B 13.06
Phibro Animal Health (PAHC) United States $1.221B 15.61
Green Thumb Industries (GTBIF) United States $1.211B 27.24
Neogen (NEOG) United States $1.137B 14.56
BioLife Solutions (BLFS) United States $1.071B 0.00
InMode (INMD) Israel $0.971B 9.78
Kestra Medical Technologies (KMTS) United States $0.810B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.703B 0.00
Owens & Minor (OMI) United States $0.695B 5.76
Curaleaf Holdings (CURLF) Canada $0.643B 0.00
CeriBell (CBLL) United States $0.619B 0.00
Evolus (EOLS) United States $0.597B 0.00
Tilray Brands (TLRY) Canada $0.594B 0.00
Valneva SE (VALN) France $0.497B 0.00
Capricor Therapeutics (CAPR) United States $0.465B 0.00
Surmodics (SRDX) United States $0.429B 0.00
SNDL (SNDL) Canada $0.363B 0.00
VAREX IMAGING (VREX) United States $0.347B 12.77
Quanterix (QTRX) United States $0.327B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.322B 0.00
Sanuwave Health (SNWV) United States $0.299B 0.00
Cerus (CERS) United States $0.279B 0.00
Viemed Healthcare (VMD) United States $0.277B 23.40
Sanara MedTech (SMTI) United States $0.269B 0.00
ZimVie (ZIMV) United States $0.268B 12.19
Cresco Labs (CRLBF) United States $0.265B 0.00
Aurora Cannabis (ACB) Canada $0.256B 76.00
Brainsway (BWAY) Israel $0.243B 64.35
OraSure Technologies (OSUR) United States $0.227B 0.00
Canopy Growth (CGC) Canada $0.226B 0.00
Biote (BTMD) United States $0.222B 6.25
TriSalus Life Sciences (TLSI) United States $0.196B 0.00
Organigram Global (OGI) Canada $0.192B 0.00
High Tide (HITI) Canada $0.190B 0.00
Utah Medical Products (UTMD) United States $0.187B 15.23
Omeros (OMER) United States $0.183B 0.00
Verano Holdings (VRNOF) United States $0.181B 0.00
Vireo Growth (VREOF) United States $0.150B 0.00
Exagen (XGN) United States $0.148B 0.00
FitLife Brands (FTLF) United States $0.127B 15.61
TerrAscend (TSNDF) Canada $0.101B 0.00
Fonar (FONR) United States $0.097B 12.47
MacroGenics (MGNX) United States $0.093B 0.00
Jin Medical (ZJYL) China $0.091B 0.00
Apyx Medical (APYX) United States $0.090B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.085B 0.00
Veru (VERU) United States $0.085B 0.00
Quipt Home Medical (QIPT) United States $0.078B 0.00
Zynex (ZYXI) United States $0.073B 0.00
InterCure (INCR) Israel $0.072B 0.00
Agape ATP (ATPC) $0.069B 0.00
Jushi Holdings (JUSHF) United States $0.067B 0.00
Cytosorbents (CTSO) United States $0.066B 0.00
ImmuCell (ICCC) United States $0.060B 0.00
Nephros (NEPH) United States $0.041B 55.57
Modular Medical (MODD) United States $0.039B 0.00
United-Guardian (UG) United States $0.037B 12.84
Safety Shot (SHOT) United States $0.032B 0.00
Rockwell Medical (RMTI) United States $0.032B 0.00
Allurion Technologies (ALUR) United States $0.019B 0.00
INLIF (INLF) $0.016B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
IM Cannabis (IMCC) Canada $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Senestech (SNES) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00